Dr. Geoffrey Charles Evans is a Canonsburg, Pennsylvania based Dentist who is specialized in General Practice Dentistry. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. Geoffrey Charles Evans is DS040984 for General Practice Dentistry in Pennsylvania. His current practice location is 100 Houston Sq, Suit 1a, Canonsburg. Patients can reach him at 724-746-5330.
Dr. Geoffrey Charles Evans is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Geoffrey Charles Evans speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1639622624
NPI Enumeration Date:
26 Jul, 2016
NPI Last Update On:
26 Jul, 2016
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Geoffrey Charles Evans are as mentioned below.
License Number
Specialization
State
Status
DS040984
General Practice Dentistry
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
100 Houston Sq, Suit 1a Canonsburg, Pennsylvania
Zip:
15317-1469
Phone Number:
724-746-5330
Patients can reach Dr. Geoffrey Charles Evans at 100 Houston Sq, Suit 1a, Canonsburg, Pennsylvania or can call to book an appointment on 724-746-5330. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.